Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 887-896
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.887
Table 1 Comparison of baseline data between the two groups, n (%)
Normal information
Reconstruction group (n = 40)
Regular group (n = 58)
t/χ2 value
P value
Age (yr)58.6 ± 7.059.0 ± 6.6-0.28770.77422
Body mass index (kg/m2)22.6 ± 1.922.8 ± 2.3-0.45330.65132
Sex1.3190.251
Male28 (70)34 (58.62)
Female12 (30)24 (41.38)
Surgical approach1.2270.746
Cholangiocarcinoma resection11 (27.5)22 (37.93)
Left liver + Caudate lobe13 (32.5)15 (25.86)
Right liver + Caudate lobe12 (30)16 (27.59)
Other types4 (10)5 (8.62)
Bismuth-Corlette type1.1790.758
I type14 (35)25 (43.1)
II type16 (40)21 (36.21)
III type8 (20)8 (13.79)
IV type2 (5)4 (6.9)
Regional lymph node metastasis0.7640.382
Yes18 (45)21 (36.21)
No22 (55)37 (63.79)
Adjuvant chemotherapy1.6960.193
Yes35 (87.5)55 (94.83)
No5 (12.5)3 (5.17)
Table 2 Comparison of surgical trauma indexes between the two groups (mean ± SD)
Group
n
Operation time (min)
Surgical bleeding (mL)
Gastrointestinal function recovery time (h)
Hospital stay (d)
Reconstruction group4011.36 ± 1.03906.8 ± 155.373.6 ± 13.021.61 ± 3.9
Regular group589.71 ± 0.81720.3 ± 160.164.8 ± 11.019.3 ± 3.2
t value8.8635.7373.6123.210
P value0.0000.0000.0000.002
Table 3 Comparison of the effect of operational resection between the two groups, n (%)
Group
n
R0 excision
Non-R0 resection
Reconstruction group4036 (90.00)4 (10.00)
Regular group5842 (72.41)16 (27.59)
χ24.507
P value0.034
Table 4 Comparison of Karnofsky performance status scores between the two groups of patients before and after operation (mean ± SD, scores)
Group
n
Preoperative
2 wk after surgery
8 wk after surgery
Reconstruction group4075.1 ± 4.266.9 ± 5.076.7 ± 4.8
Regular group5873.7 ± 3.564.0 ± 5.775.4 ± 5.0
χ21.7932.6001.286
P value0.0760.0110.202
Table 5 Comparison of liver function indexes between two groups of patients (mean ± SD)
Index
Preoperative
1 d after operation
3 d after operation
ALT (U/L)
Reconstruction group78.9 ± 19.6451.2 ± 88.1357.1 ± 93.0
Regular group83.0 ± 20.1489.8 ± 94.7401.2 ± 85.0
t value-1.003-2.040-2.429
P value0.3190.0440.017
AST (U/L)
Reconstruction group83.5 ± 28.0438.1 ± 93.0395.8 ± 81.7
Regular group80.0 ± 24.6470.7 ± 87.2441.5 ± 96.1
t value0.654-1.770-2.456
P value0.5150.0800.016
TBIL (μmol/L)
Reconstruction group144.3 ± 35.1122.2 ± 28.044.1 ± 13.0
Regular group138.5 ± 37.3118.0 ± 26.940.0 ± 12.5
t value0.7750.7471.570
P value0.4400.4570.120
Table 6 Observation of complication rate
Group
n
Biliary fistula
Liver failure
Incision infection
Urinary tract infection
Lung infection
Complication rate, n (%)
Reconstruction group401124311 (27.50)
Regular group583235619 (32.76)
χ20.308
P value0.579
Table 7 Two-year survival rate observation, n (%)
Group
n
Survive
Death
Reconstruction group4017 (42.50)23 (57.50)
Regular group5823 (39.66)35 (60.34)
χ20.079
P value0.778